The cost effectiveness of a pharmacist reviewing medication among the elderly in the community

Australasian Journal on Ageing

Volumn 20, Issue 4, 2001, Pages 179-186

  Harris, Anthony ^a   Gospodarevskaya, Elena ^a   Callaghan, Jennifer ^b   Story, Ian ^c  

^a MONASH UNIVERSITY   (Australia)

^b NATIONAL AGEING RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 17844408354     PISSN: 14406381     EISSN: 17416612     Source Type: Journal    
DOI: 10.1111/j.1741-6612.2001.tb00383.x     Document Type: Article

References (18)

1. McCarty S. The report to the National Polypharmacy Task Force, 1990.
2. Kurowski W. Polypharmacy and older people. Melbourne: Australian Council on the Ageing, 1989.
3. Callaghan J, Katz B. Adverse drug reactions mimicking disease Australasian Journal on Ageing 1999; 18:198-200
4. Australian Bureau of Statistics. National-Health Survey: Use of Medication, Australia. Cat. No. 4377. Canberra, 1995
5. Callaghan J, Harvey K, Story I. Geriatritian-initiated medication recommendation: Are they implemented? Lincoln Gerontology Centre, La Trobe University, 1993.
6. Callaghan J, Story I. The impact of an ACAT clinical/consultant pharmacist on medication use by older people. Lincoln Gerontology Centre, La Trobe University, 1993.
7. Hsia Der E, Rubenstein L, Choy G. The benefits of in-home pharmacy evaluation for older persons. Journal of the American Geriatrics Society 1995; 45: 533-543.
8. Pharmacy Practice Research Group. The Community Pharmacy Model Practices Project. University of South Australia, 1997.
9. Rumble R. Cost-effectiveness of consultant pharmacist services provided to hostel residents. Pharmaceutical Benefits Scheme Education Program, 1996.
10. Stewart S, Pearson S, Luke C, Horowitz J. Effects of home-based intervention on unplanned readmissions and out-of-hospital deaths. Journal of the American Geriatrics Society 1998; 46: 174-180.
11. Drurnmond MF Output measurement for resource allocation decisions in health care, Oxford Review of Economic Policy 1990; 5:470-485
12. Johannesson M, Weinstein M. On the decision rules of cost-effectiveness analysis. Journal of Health Economics 1993; 12:459-467.
13. Harris A, Wraith D. Cost effectiveness of treatments for osteoporosis: drug therapy and the risk of hip fracture. Paper presented at the 20th Conference of Australian Health Economists, Sydney, July 1998.
14. Jackson T, Wilson R, Watts J, Lane L, Bayliss-McCulloch J. 1997 Victorian Cost Weights Study. Final Report for the Department of Human Services Victoria. 1998.
15. Commonwealth Department of Health and Aged Care. Medicare Benefits Schedule Book. Australian Government Publishing Service, 1996.
16. Hawthorne G, Richardson J, Osborne R, McNeil H. The Assessment of Quality of Life (AQoL) instrument. Construction, initial validation & utility scaling. The Centre for Health Program Evaluation Working Paper 76, Monash University, 1997.
17. Ware J, Snow K. SF-36 health survey: manual and interpretation guide. The Health Institute, New England Medical Centre, Boston, 1986.
18. Australian Bureau of Statistics. National Health Survey: SF-36 Population Norms. Cat. No. 4399. Canberra, 1995